Feb. 28, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE:31R) (‘Revive’ or the ‘Company’), a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products, today announced its results for the three and six months ended December 31, 2018.
Read more
Revive Therapeutics Announces Results for the Three and Six Months Ended December 31, 2018
